A detailed history of J. Safra Sarasin Holding Ag transactions in Incyte Corp stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 8,406 shares of INCY stock, worth $875,484. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,406
Previous 44,061 80.92%
Holding current value
$875,484
Previous $3.74 Billion 77.78%
% of portfolio
0.01%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

SELL
$83.8 - $108.26 $2.99 Million - $3.86 Million
-35,655 Reduced 80.92%
8,406 $830 Million
Q3 2025

Nov 03, 2025

BUY
$67.27 - $86.96 $2.96 Million - $3.83 Million
44,061 New
44,061 $3.74 Billion
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $46,723 - $55,917
-815 Reduced 3.04%
25,998 $1.72 Billion
Q2 2024

Jul 30, 2024

BUY
$51.18 - $63.75 $1.37 Million - $1.71 Million
26,813 New
26,813 $1.63 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.